LoadingLoadingLoading37 funds hold it.Insiders net selling.
Net selling: insiders sold $1.7M and bought $1M on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsLast report
Oct 20, 2026
Financial period
Q3 2026
Earnings per share
$5.03 expected
Revenue
$888.0M expected
Estimates as of Nov 2, 2026
EPS expected
$4.76 to $5.31
Revenue expected
10 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 20, 2026 | $5.11est. $5.03 | +1.66%beat | $892.0Mest. $888.0M+0.45% | +12.4%from $793.4M |
| Jun 30, 2026Reported Jul 21, 2026 | $4.94est. $4.98 | -0.84%in line | $867.0MCompany release | +12.2%from $772.7M |
| Mar 31, 2026Reported Apr 21, 2026 | $4.55est. $4.46 | +2.13%beat | $850.8MSEC filing | +14.1%from $745.8M |
| Dec 31, 2025Reported Jan 28, 2026 | $4.66est. $4.59 | +1.56%beat | $822.5MAlpha Vantage | +10.6%from $743.5M |
| Sep 30, 2025Reported Oct 28, 2025 | $4.47est. $4.37 | +2.29%beat | $793.4MSEC filing | +9.5%from $724.7M |
| Jun 30, 2025Reported Jul 22, 2025 | $4.17est. $4.15 | +0.48%in line | $772.7MSEC filing | +9.1%from $707.9M |
| Mar 31, 2025Reported Apr 22, 2025 | $4.00est. $3.90 | +2.56%beat | $745.8MSEC filing | +9.7%from $680.0M |
| Dec 31, 2024Reported Jan 29, 2025 | $4.18est. $3.95 | +5.82%beat | $743.5MAlpha Vantage | +7.7%from $690.1M |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $822.5M | $850.8M | $867.0M | $892.0M |
| Cost of what it sold | $143.4M | $141.8M | $149.9M | $152.2M |
| Gross profit | $679.1M | $709.0M | $717.1M | $739.8M |
| What it spent | ||||
| Research and development | $41.1M | $49.6M | $46.0M | $47.6M |
| Sales and admin | $43.0M | $69.0M | $46.2M | $48.2M |
| Other operating costs | $131.4M | $133.5M | $137.4M | $141.9M |
| Total operating expenses | $215.5M | $252.1M | $229.6M | $237.7M |
| What was left | ||||
| Operating profit | $463.6M | $456.9M | $487.5M | $502.1M |
| Interest on debt | $63.6M | $69.1M | $71.0M | $74.8M |
| Profit before tax | $388.8M | $389.2M | $417.3M | $427.9M |
| Tax | $104.2M | -$16.8M | $75.3M | $76.9M |
| Net profit | $284.7M | $406.0M | $342.0M | $351.0M |
| EBITDA | $508.0M | $512.9M | $545.0M | $554.4M |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is mixed
MSCI Inc. (MSCI) Stock forecasts
BullishOct 31MSCI Inc. (MSCI) Stock forecasts
BullishOct 31FactSet Research stock: BMO lifts price target to USD 314
NeutralOct 30Jakarta Composite Index May Face Continued Pressure as Foreign Net Selling Hits IDR 1.52 Trillion and MSCI Uncertainty Weighs
Leans bearishOct 30Molina Healthcare Inc. stock outperforms competitors on strong trading day
NeutralOct 30iShares Edge MSCI Multifactor USA ETF (LRGF) Seasonal returns chart
NeutralOct 30Xtrackers MSCI World Information Technology UCITS ETF Overview (XMIT)
NeutralOct 30REG - iShares V PLC - iShares MSCI Japan Climate Tran Aware UCITS ETF
NeutralOct 30
